Product Information
Lucyoside B is a triterpenoid saponin that inhibits the proinflammatory transcription factor NF-κB. It has been shown to inhibit activation of p38 phosphorylation and the expression of proinflammatory cytokines in a mechanistically translational manner. Lucyoside B also inhibits the production of MCP-1, which enhances monocyte recruitment to sites of inflammation. This compound is being studied as a potential treatment for inflammatory diseases such as rheumatoid arthritis and psoriasis.
Chemical properties
Technical inquiry about: 3D-RDA17419 Lucyoside B
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.